Screening Circular RNAs Related to Acquired Gefitinib Resistance in Non-small Cell Lung Cancer Cell Lines

Background: Gefitinib is a tyrosine kinase inhibitor (TKI) of epidermal growth factor receptor (EGFR) used to treat EGFR mutation-positive patients with non-small cell lung cancer (NSCLC). However, the efficacy of gefitinib is limited by the development of acquired resistance. Studies have shown tha...

Descripción completa

Detalles Bibliográficos
Autores principales: Wen, Chunjie, Xu, Ge, He, Shuai, Huang, Yutang, Shi, Jingjing, Wu, Lanxiang, Zhou, Honghao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2020
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7171488/
https://www.ncbi.nlm.nih.gov/pubmed/32328186
http://dx.doi.org/10.7150/jca.39783

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7171488/
https://www.ncbi.nlm.nih.gov/pubmed/32328186
http://dx.doi.org/10.7150/jca.39783

Ejemplares similares